|  | M/z4276 | M/z4292 | M/z8129 | M/z8941 |
---|---|---|---|---|---|
 | n | Median intensity (IQR) | Median intensity (IQR) | Median intensity (IQR) | Median intensity (IQR) |
TNM stage | Â | Â | Â | Â | Â |
   IIA | 26 | 13.00 (1.79–83.10) | 19.51 (8.07–54.23) | 26.27 (23.48–30.07) | 33.56 (24.09–50.43) |
   IIB | 10 | 4.97 (1.33–17.24) | 11.44 (4.83–15.79) | 25.44 (16.56–27.75) | 30.49 (20.16–34.59) |
   III | 11 | 11.88 (4.89–24.69) | 15.86 (9.88–22.87) | 25.70 (15.68–26.54) | 37.55 (25.26–47.29) |
p-value* | 47 | .340 | .211 | .203 | .473 |
p-trend# | 47 | .553 | .368 | .075 | .667 |
Tumor size | Â | Â | Â | Â | Â |
   0.5–2 cm | 18 | 10.24 (1.36–85.58) | 18.44 (5.44–63.09) | 26.53 (22.86–30.08) | 30.48 (23.24–61.21) |
   > 2 cm | 29 | 11.88 (3.97–24.51) | 12.21 (8.71–24.28) | 25.90 (19.08–27.45) | 32.90 (24.04–44.16) |
p-value†| 47 | .844 | .526 | .204 | .896 |
Lymph node involvement | Â | Â | Â | Â | Â |
   No | 9 | 24.34 (5.99–72.28) | 25.69 (9.91–54.35) | 26.48 (23.33–30.29) | 38.92 (27.68–53.99) |
   Yes | 38 | 8.66 (1.87–24.37) | 13.13 (5.97–23.74) | 25.81 (18.87–27.65) | 30.49 (23.30–43.31) |
p-value†| 47 | .137 | .144 | .224 | .224 |
Differentiation | Â | Â | Â | Â | Â |
   High-Intermediate | 25 | 11.04 (2.99–24.47) | 14.06 (7.86–22.52) | 25.72 (19.84–27.45) | 31.27 (24.13–42.65) |
   Low | 21 | 19.90 (2.98–60.12) | 17.06 (8.71–44.18) | 26.54 (19.68–29.79) | 28.99 (23.34–45.88) |
p-value†| 46 | .635 | .384 | .360 | .903 |